| 摘要 |
The present invention relates to a pharmaceutical composition comprising:
(a) a botulinum toxin;
(b) a first excipient, wherein the first excipient is an albumin;
(c) a second excipient; and
(d) wherein the weight to weight ratio of the first excipient to the second excipient present in the pharmaceutical composition is greater than 0.6 and less than about 100. |
